换一批
换一批Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the U.S. Food and Drug Administration Adverse Event Reporting System.
作者：
主题词
美国(United States);人类(Humans);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);胆囊(Gallbladder);美国食品和药物管理局(United States Food and Drug Administration);糖尿病, 2型(Diabetes Mellitus, Type 2);二肽基肽酶4(Dipeptidyl Peptidase 4);药物副反应报告系统(Adverse Drug Reaction Reporting Systems)
DOI
10.2337/dc22-1095
PMID
36534433
发布时间
2023-03-22
- 浏览2
Diabetes care
e72-e73页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
